The Clinical Efficacy Of Paremyd.

Pupillary dilation to perform binocular indirect ophthalmoscopy has become a routine part of an optometric comprehensive exam. Most "patients find the resulting photophobia," stinging upon instillation, and "incapacity of near vision to be an inconvenience. The effects of pupillary dilation have been reported to last from four to eight hours. Paremyd, a new mydriatic agent, dilates the pupil sufficiently for a binocular indirect ophthalmoscopy but with significantly reduced or minimal side effects. This drug produces minimal stinging; therefore, no anesthetic is needed. The dilation is
reported to last four to six hours and cycloplegia is eliminated in 60 to 90 minutes. Paremyd is a combination of two types of dilators: 1% hydroxyamphetamine (Paredrine), which stimulates dilation and .25% tropicamide, which inhibits constriction. This new dilating agent reportedly eliminates the two most common complaints among dilated patients: near-point blurring and stinging.